Improving care for patients with drug-resistant epilepsy
Optimizing Care for Patients with Drug-Resistant Epilepsy
This study is all about creating a helpful mobile app that makes it easier for people with drug-resistant epilepsy to share what matters most to them with their doctors, like their mental health and daily life, so they can work together to improve their overall care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11067774 on NIH RePORTER |
What this research studies
This research focuses on enhancing communication between patients with drug-resistant epilepsy and their healthcare providers. It aims to develop a mobile health tool that helps patients express their care priorities, which may include factors beyond just seizure control, such as mental health and cognitive function. By aligning treatment goals with patient priorities, the research seeks to improve overall patient-centered outcomes. The approach involves designing and testing this communication tool to ensure it meets the needs of patients effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with drug-resistant epilepsy who are seeking better management of their condition.
Not a fit: Patients who have well-controlled epilepsy or those who do not have access to mobile health technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved quality of life and better clinical outcomes for patients with drug-resistant epilepsy.
How similar studies have performed: Previous research has shown that communication tools can significantly enhance patient-centered outcomes in other clinical areas, suggesting potential success for this novel approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hill, Chloe E — University of Michigan at Ann Arbor
- Study coordinator: Hill, Chloe E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.